Liver transplantation (LT) is the standard treatment for hepatocellular carcinoma (HCC) and end-stage liver disease, with excellent long-term outcomes despite the increasing use of extended criteria donors due to organ shortage. As traditional evaluation criteria have become insufficient, new indicators such as Arterial and Biliary Complication-Free Survival (ABCFS) have been developed to better assess post-transplant outcomes.
Primary objective: To assess, in a large-scale study, whether the procurement technique influences liver transplantation outcomes in terms of arterial and biliary complication-free survival.
Patients aged 18 years or older at the time of inclusion
Listed on the national waiting list of the Agence de la Biomédecine (ABM)
Undergoing a first liver transplantation in France
Receiving a whole liver graft
Pancreas procurement
Multiorgan transplantation
Split liver transplantation (shared grafts)
Retransplantation